Home
/ EdiGENE
/ Competitors

EdiGENE Competitors and Similar CompaniesClear all

StrideBio's competitors and similar companies include Maze Therapeutics, EpiBiologics and Pluri Biotech.

	StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.	Maze Therapeutics Maze Therapeutics is a clinical-stage biopharmaceutical company.	EpiBiologics EpiBiologics is a company that provides a protein degradation platform.	Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
Founding Date	Founding Date 2015	Founding Date 2018	Founding Date 2022	Founding Date 2003
Type	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare Technology biotech genetics platform therapy	Tags Technology biotech drug development genetics pharma platform therapy	Tags Technology biotech platform therapy	Tags Technology biotech platform therapy
Locations	Locations US HQ	Locations South San Francisco, US HQ Redwood City, US South San Francisco, US	Locations San Mateo, US HQ	Locations Haifa, IL HQ Potsdam, DE
Employees	Employees 5	Employees 121	Employees 40	Employees 106
Financial
Cost of goods	Cost of goods N/A	Cost of goods $6.3m (FY, 2025)	Cost of goods N/A	Cost of goods $682k (FY, 2025)
Net income	Net income N/A	Net income ($131.1m) (FY, 2025)	Net income N/A	Net income ($23.3m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 81.5m (over 5 years ago)	Latest funding round N/A	Latest funding round $ 50m (over 3 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 97.2m	Total funding raised $ 191m	Total funding raised $ 50m	Total funding raised $ 78.4m